Verified against court and regulatory records · No upfront fees · Your information is never sold
Quick Eligibility Review
Answer one question at a time. This usually takes under 2 minutes.
Check your eligibility — free
Answer 2-3 quick questions to review your potential case.
Free · Confidential · About 2 minutes · A case specialist responds within 1 business day
Your answers are never sold or shared without your consent.
Why Black Women Are Disproportionately Affected
Black women are the primary consumers of chemical hair relaxers in the United States. Approximately 60% of participants who reported using straighteners in the NIH Sister Study were self-identified Black women. Black women use these products more frequently, begin use at younger ages (often in childhood), and consequently accumulate higher lifetime EDC exposure than any other demographic group.
The Marketing Machine
For decades, hair relaxer manufacturers aggressively marketed their products to Black women and girls through advertising in Black-owned media: Ebony, Jet, Essence, BET. Product names ("Dark & Lovely," "African Pride," "Just for Me") explicitly targeted Black consumers. Products were positioned as necessities for professional appearance — reinforcing discriminatory beauty standards that penalized natural Black hair.
Workplace Discrimination and Coercive Pressure
The CROWN Act movement exists because Black women faced documented employment and educational consequences for wearing natural hair. This discrimination created a coercive environment where chemical straightening felt mandatory for career advancement. The litigation argues that hair relaxer manufacturers profited from this systemic pressure while hiding the cancer risks of their products.
The Uterine Cancer Mortality Disparity
Black women die of uterine cancer at twice the rate of white women — one of the largest racial cancer mortality disparities documented in the United States. The hair relaxer litigation raises a pointed question: how much of this disparity was caused by an industry that marketed carcinogen-containing products specifically to Black women without disclosing the cancer risk?
Environmental Justice Framework
The Environmental Working Group found that personal care products marketed to Black women contain significantly higher concentrations of hazardous chemicals than mainstream products. The hair relaxer litigation is part of a broader environmental justice movement recognizing that communities of color bear disproportionate exposure to toxic chemicals — not by coincidence, but through corporate marketing decisions.
Research & evidence
Scientific Evidence
Hair Relaxer Use and Risk of Uterine Cancer in the Black Women's Health Study
Bertrand KA, Coogan PF, Palmer JR (2023). Environmental Research
View on PubMedUse of Straighteners and Other Hair Products and Incident Uterine Cancer
Chang CJ, O'Brien KM, Keil AP, Gaston SA, Jackson CL, Sandler DP, White AJ (2022). Journal of the National Cancer Institute
View on PubMedUse of Hair Products in Relation to Ovarian Cancer Risk
White AJ, Sandler DP, et al. (2021). Carcinogenesis
View on PubMedFAQ
Frequently Asked Questions
Dive deeper
Related Guides
- Hair Relaxer Uterine CancerUterine cancer is the primary injury in the hair relaxer litigation. The NIH Sister Study found a 155% increased risk (HR 2.55) for frequent users. Approximately 67,000 Americans are diagnosed with uterine cancer annually.
- Hair Relaxer Ovarian CancerThe Sister Study found hair relaxer users face a 2.19x increased risk of ovarian cancer. Ovarian cancer is often called the "silent killer" because symptoms are vague until advanced stages, making early detection difficult.
- Hair Relaxer EndometriosisChemical hair relaxers contain EDCs linked to endometriosis — a painful condition where uterine-like tissue grows outside the uterus. Phthalates and parabens in relaxers promote endometrial implant growth through estrogen mimicry.
- Hair Relaxer Settlement AmountsNo hair relaxer cases have settled or gone to trial yet. Attorney estimates project $90,000–$1,000,000+ depending on injury type and severity. Bellwether trials expected in 2027 will establish actual case values.
- L'Oréal Hair Relaxer LawsuitL'Oréal is the primary defendant in the hair relaxer MDL through its subsidiary SoftSheen-Carson, maker of Dark & Lovely and Optimum Care. L'Oréal is the world's largest beauty company with €38+ billion in annual revenue.
- Revlon Dark and Lovely LawsuitRevlon is a defendant in the hair relaxer MDL despite filing bankruptcy in 2022. Revlon maintains insurance coverage and allocated ~$44 million for hair relaxer claims in its reorganization plan. Products include Creme of Nature and Revlon Realistic.
- Hair Relaxer Chemical ExposureHair relaxers contain at least 45 endocrine-disrupting chemicals across 10 chemical classes. 84% of these chemicals are NOT listed on product labels. The chemicals enter the body through the scalp, whose protective barrier is compromised by the relaxing process itself.
The full investigation